World's Best Scientists 2026 revealed!
Raymond F. Schinazi

Raymond F. Schinazi

D-Index & Metrics

Biology and Biochemistry

D-Index
102
Citations
39695
World Ranking
1360
National Ranking
787

Overview

Raymond F. Schinazi is affiliated with Emory University in the United States. Their research predominantly covers fields related to medicine, with a particular focus on infectious diseases, epidemiology, molecular biology, virology, and hepatology. The body of work includes a significant number of publications documenting scientific advancements in these areas.

The scientist's research topics include:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Hepatitis B Virus Studies
  • SARS-CoV-2 detection and testing

Frequent publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Biological Chemistry
  • Viruses
  • Molecules
  • UNC Libraries

Among recent papers authored or co-authored by Schinazi are:

  • "COVID-19: Discovery, diagnostics and drug development," 2020, Journal of Hepatology
  • "Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template," 2021, Journal of Biological Chemistry
  • "β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells," 2021, The Journal of Infectious Diseases
  • "Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques," 2020, Cell
  • "Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020," 2020, Emerging Infectious Diseases

Raymond F. Schinazi has collaborated extensively with several co-authors throughout their career. Some of the most frequent collaborators include:

  • Leda Bassit
  • Franck Amblard
  • Baek Kim
  • Sijia Tao
  • Keivan Zandi

Their work spans infectious disease mechanisms, antiviral drug development, and clinical research related to pandemics and viral infections. This range of topics reflects interdisciplinary expertise intersecting virus biology, therapeutic innovation, and epidemiological surveillance within the scope of global health challenges.

Best Publications

  • A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

    Lieven Stuyver;Sija De Gendt;Caroline Van Geyt;Fabien Zoulim

  • Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

    Shin-Lian Doong;Ching-Hwa Tsai;Raymond F. Schinazi;Dennis C. Liotta

  • Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

    Ugo Pradere;Ethel C. Garnier-Amblard;Steven J. Coats;Franck Amblard

  • Zika Virus Infects Human Placental Macrophages

    Kendra M. Quicke;Kendra M. Quicke;James R. Bowen;James R. Bowen;Erica L. Johnson;Circe E. McDonald;Circe E. McDonald

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Polyoxometalate HIV-1 Protease Inhibitors. A New Mode of Protease Inhibition

    Deborah A. Judd;James H. Nettles;Neysa Nevins;James P. Snyder

  • Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.

    Lin Tai-Shun;Raymond F. Schinazi;William H. Prusoff

  • In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora

    Yuh-Meei Lin;Herbert Anderson;Michael T. Flavin;Yeah-Huei S. Pai

  • Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.

    C.N. Chang;S.L. Doong;J.H. Zhou;J.W. Beach

  • Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

    Mirjam B. Zeisel;Julie Lucifora;William S. Mason;Camille Sureau

  • Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.

    L Stuyver;A Wyseur;A Rombout;J Louwagie

  • HCV direct‐acting antiviral agents: the best interferon‐free combinations

    Raymond Schinazi;Philippe Halfon;Patrick Marcellin;Tarik Asselah

  • Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV)

    J. Warren Beach;Lak S. Jeong;Antonio J. Alves;Douglas Pohl

  • β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.

    Shuntai Zhou;Collin S Hill;Sanjay Sarkar;Longping V Tse

  • Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease.

    Edward M. Kennedy;Leda C. Bassit;Henrik Mueller;Anand V.R. Kornepati

  • Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture

    Lieven J. Stuyver;Tony Whitaker;Tamara R. McBrayer;Brenda I. Hernandez-Santiago

  • In situ complexation directs the stereochemistry of N-glycosylation in the synthesis of oxathiolanyl and dioxolanyl nucleoside analogues

    Woo Baeg Choi;Lawrence J. Wilson;Suresh Yeola;Dennis C. Liotta

  • Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.

    L. S. Jeong;R. F. Schinazi;J. W. Beach;H. O. Kim

  • Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

    Chung K. Chu;Raymond F. Schinazi;Moon K. Ahn;Giliyar V. Ullas

  • New Manzamine Alkaloids with Activity against Infectious and Tropical Parasitic Diseases from an Indonesian Sponge

    Karumanchi V. Rao;Bernardo D. Santarsiero;Andrew D. Mesecar;Raymond F Schinazi

Frequent Co-Authors

Chung K. Chu
Chung K. Chu University of Georgia
Baek Kim
Baek Kim Emory University
Yung-Chi Cheng
Yung-Chi Cheng Yale University
Dong-Hyun Kim
Dong-Hyun Kim Kyung Hee University
Mark T. Hamann
Mark T. Hamann Medical University of South Carolina
Charles M. Rice
Charles M. Rice Rockefeller University
Steven P. Nolan
Steven P. Nolan Ghent University
Jeffrey S. Glenn
Jeffrey S. Glenn Stanford University
Kyong-Mi Chang
Kyong-Mi Chang University of Pennsylvania
Wenhui Li
Wenhui Li Tsinghua University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Biology and Biochemistry opens a range of online degree and certificate options that can boost your career potential. Many students pair these studies with fields focusing on human health, exercise, and patient care. For example, you might consider an exercise science online degree if you're interested in the science behind fitness and performance, or pursue one of the best online kinesiology degree programs for a broader understanding of body movement and mechanics.

For those with a background in biochemistry or biology looking toward healthcare, quick pathway options like the shortest pmhnp certificate program can prepare you for advanced roles in mental health nursing. Similarly, online fnp programs are available for those aiming to become Family Nurse Practitioners, often enabling fast completion for those who already have a graduate degree. These pathways let you leverage your science background while expanding your career opportunities in both clinical and research settings.

Best Scientists Citing Raymond F. Schinazi

Trending Scientists

Recently Published Articles